FDA's recent IRB guidance more style than substance
The U.S. Food and Drug Administration (FDA) recently issued a final guidance document for Institutional Review Boards (IRBs), clinical investigators and sponsors regarding "Considerations When...
View ArticleFacebook calls in the philosophers
Facebook's announcement — establishing guidelines, review processes, training and enhanced transparency for research projects — marks another milestone in the emergence of data ethics as a crucial...
View ArticleProposed changes to HHS 'Common Rule' are of little benefit
Recently proposed changes to the "Common Rule" by the U.S. Department of Health and Human Services (HHS) and various other federal agencies, while aiming to enhance human subject protections for...
View Article
More Pages to Explore .....
